You are not logged in.
Login to update your contact information or edit your email preferences, or Register to create an account.
FDA currently allows the use, on a case-by-case basis, of an
investigational drug outside of a clinical trial to treat a patient with a
serious or immediately life-threatening disease or condition who has no
comparable or satisfactory alternative treatment options. However, FDA often
denies this access. A new bill, to be introduced shortly, would change FDA’s
“compassionate use” rule so that individuals who have exhausted all
conventional cancer treatments can have all of their treatment choices honored
without needing to obtain federal government approval—essentially removing FDA
from the process.
Under the Compassionate Care Act, any patient diagnosed with
a terminal illness, for whom a physician determines that FDA-approved drugs are
likely not curative, may obtain access to any experimental drug upon execution
of an informed consent without the need for FDA approval.
Please ask your representative to support the Compassionate
Care Act when it is introduced, and ask your senators to introduce similar
legislation in the Senate.
Please personalize and add your own comments if you have time!
The Compassionate Care Act
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]